Patent · US Active

Anti-CD40 monoclonal antibody

US7537763B2 · kind B2 · utility

29Cited by
10References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 5, 2006
Grant dateMay 26, 2009
Priority date—
Expiry dateOct 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.